Skip Navigation



Carcinogenesis Advance Access published online on November 26, 2008

Carcinogenesis, doi:10.1093/carcin/bgn269
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
30/2/300    most recent
bgn269v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Suh, Y.
Right arrow Articles by Mukhtar, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suh, Y.
Right arrow Articles by Mukhtar, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-{kappa}B signaling pathways

Yewseok Suh1, Farrukh Afaq1, Jeremy J. Johnson2 and Hasan Mukhtar1

1 Department of Dermatology, School of Medicine and Public Health
2 Division of Pharmacy Practice, School of Pharmacy, University of Wisconsin, Madison, WI, USA

Send correspondence to: Hasan Mukhtar, Ph.D., Helfaer Professor of Cancer Research, Director and Vice Chair of Research, Department of Dermatology, University of Wisconsin, Medical Sciences Center, Room #B25, 1300 University Avenue, Madison, WI 53706. Phone: (608) 263-3927; Fax: (608) 263-5223, Email: hmukhtar{at}wisc.edu

Overexpression of cyclooxygenase 2 (COX2) and uncontrolled Wnt signaling pathway have long been suggested to play crucial roles in colorectal cancer. Studies show that selective COX2 inhibitors possess great potential as chemopreventive agents for colon cancer. Recent studies suggest that targeting COX2 and epidermal growth factor receptor (EGFR) may provide better therapeutic strategy than inhibiting either single target and that this may alleviate the problem of COX2 inhibitor-associated side effects. Therefore, there have been intensive efforts to develop novel dietary substances that target COX2 and EGFR activation. Fisetin is a naturally occurring flavonoid commonly found in various vegetables and fruits. We found that the treatment of COX2 overexpressing HT29 human colon cancer cells with fisetin (30–120 µM) resulted in induction of apoptosis, downregulation of COX2 protein expression without affecting COX1, and inhibited the secretion of PGE2. Treatment of cells with fisetin also inhibited Wnt signaling activity through downregulation of β-catenin and TCF 4, and decreased the expression of target genes such as cyclin D1 and MMP7. Fisetin treatment of cells also inhibited the activation of EGFR and nuclear factor kappa B (NF-{kappa}B). Finally, the formation of colonies in soft agar was suppressed by fisetin treatment. Taken together, we provide evidence that the plant flavonoid fisetin can induce apoptosis and suppress the growth of colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-{kappa}B signaling pathways. We suggest that fisetin could be a useful agent for prevention and treatment of colon cancer.

Key Words: Fisetin • colon cancer • COX2 • Wnt • β-catenin

Received August 12, 2008; revised October 27, 2008; accepted November 14, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.